Quantitative Systems Pharmacology (QSP) Summit Cambridge 2024

May 1, 2024 | 9am - 5pm | Cambridge, MA

About the Event

The Quantitative Systems Pharmacology (QSP) Summit is a free conference dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its seventh year, the QSP Summit is a one-day event featuring talks from key industry and academic researchers, a poster session, and networking time with peers.

Date: May 1, 2024

Time: 9am - 5pm ET

Venue: Le Meridien Boston Cambridge, 20 Sidney Street, Cambridge, MA 02139

qsp summit

Speakers

Alison Betts, PhD - Global Head of DMPK and Modeling, Preclinical & Translational Sciences at Takeda

Joe Bender, PhD - Computational Lab Director at United Therapeutics

Giuseppe Ciaramella, PhD - President at Beam Therapeutics

Victoria Etges Helfer, PhD - Postdoctoral Fellow at UNC/GSK

Piet van der Graaf, PharmD, PhD - SVP, Head of QSP at Certara

Linda Griffith, PhD - School of Engineering Professor of Teaching Innovation, Departments of Biological and Mechanical Engineering, Director - Center for Gynepathology Research at MIT

Jeff Kearns, PhD - Director, Translational Modeling & Simulation at Novartis Biomedical Research 

Krina Mehta, MSc - Director, Pharmacometrics at Kyowa Kirin

Dominic Whittaker, PhD - Investigator, QSP at GSK

 

Agenda

Start Time (ET)Event
9:00 AMBreakfast and registration
9:30 AMOpening remarks
9:45 AM

Piet van der Graaf, PharmD, PhD
SVP, Head of QSP at Certara

"QSP 2.0: Industrializing the Impact of Mechanistic Modeling Across the R&D Spectrum"

10:15 AM

Alison Betts, PhD
Global Head of DMPK and Modeling, Preclinical & Translational Sciences at Takeda

"Accelerating Early Development of Bispecifics and ADCs for Oncology Using QSP"

10:45 AMBreak and poster session
11:15 AM

Krina Mehta, MSc
Director, Pharmacometrics at Kyowa Kirin

"Leveraging QSP to Shape the Strategy for Early Phase Clinical Development in Immuno-Oncology: CD40 Agonistic Bispecific Antibody as a Case Study"

11:45 AM

Joe Bender, PhD
Computational Lab Director at United Therapeutics

"Evaluation of Combination Therapy Regimens in a Pulmonary Hypertension QSP Model"

12:15 PMLunch and poster session
1:00 PM

Linda Griffith, PhD
School of Engineering Professor of Teaching Innovation 
Departments of Biological and Mechanical Engineering 
Director, Center of Gynepathology Research 
Massachusetts Institute of Technology 

"Building Physiomimetic In Vitro Models of Chronic Inflammatory Diseases"

1:30 PM

Jeff Kearns, PhD
Director, Translational Modeling & Simulation at Novartis Biomedical Research

"Modeling with a Vision: Translational Insights from Discovery to Late-stage Development in Ophthalmology"

2:00 PMBreak and poster session
2:30 PM

Victoria Etges Helfer, PhD
Postdoctoral Fellow at UNC/GSK

Dominic Whittaker, PhD
Investigator, QSP at GSK

"Development of a QSP Model for HIV Viral Dynamics to Identify Optimal Combination Therapies"

3:00 PM

Pino Ciaramella, PhD
President at Beam Therapeutics

"Base Editing Next Generation in Gene Editing"

3:30 PMBreak and poster session
4:00 PM

Roundtable Discussion

Apgar (Applied BioMath), Betts (Takeda), Kearns (Novartis Biomedical Research)

Moderated by John Burke, PhD

4:45 PMClosing remarks and poster awards
5:00 PMQSP Summit concludes
summit 2023

Register